Paolo Berretta
Biographic Data
| ID | 7966910 |
|---|---|
| NAME | Paolo Berretta |
| GIVEN NAMES | Paolo |
| FAMILY NAME | Berretta |
| SIGNATURE | BERRETTA P |
| AFFILIATIONS | Istituto Superiore di Sanità |
| ORCID | 0000-0002-1748-5628 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Use of Methylphenidate Analogues as Cognitive Enhancers
Drugs involved in the treatment of Alzheimer’s disease and other cognitive deficits such as attention deficit hyperactivity disorder (ADHD), strokes, schizophrenia, and aging are medically defined as cognitive enhancers (1). Amphetamines were the first drugs used to stimulate memory consolidation and improve concentration, and were followed by non-amphetaminic central nervous system (CNS) stimulants modafinil and armodafinil, which are largely pr…
Consequences of Covid-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
Since the first outbreak of SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) in China in December 2019, the infection has rapidly spread all over the world. This new virus has caused many cases of Coronavirus disease 2019 (COVID-19), a potentially fatal respiratory syndrome (1). Due to its global diffusion, the World Health Organization rapidly issued an international warning and declared a worldwide pandemic in March 2020. Currently,…
No prominent works on this page.
Use of Methylphenidate Analogues as Cognitive Enhancers
Drugs involved in the treatment of Alzheimer’s disease and other cognitive deficits such as attention deficit hyperactivity disorder (ADHD), strokes, schizophrenia, and aging are medically defined as cognitive enhancers (1). Amphetamines were the first drugs used to stimulate memory consolidation and improve concentration, and were followed by non-amphetaminic central nervous system (CNS) stimulants modafinil and armodafinil, which are largely pr…
Consequences of Covid-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
Since the first outbreak of SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) in China in December 2019, the infection has rapidly spread all over the world. This new virus has caused many cases of Coronavirus disease 2019 (COVID-19), a potentially fatal respiratory syndrome (1). Due to its global diffusion, the World Health Organization rapidly issued an international warning and declared a worldwide pandemic in March 2020. Currently,…
Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · 2019-20 coronavirus outbreak (1 work) · Addiction (1 work) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 work) · Attention Deficit Hyperactivity Disorder (1 work) · Cognition (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · COVID-19 and Mental Health (1 work)